XtalPi Holdings Limited announced the debut of Kodexia on October 6, 2026, describing it as the industry’s first closed-loop small interfering RNA (siRNA) discovery platform to combine generative AI, first-principles-driven biological modeling, and automated experimentation, and simultaneously disclosed six proprietary therapeutic programs built on the platform. The company presented Kodexia as the expansion of its technology into nucleic acid therapeutics. The release describes siRNA…